We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Manolete Partners Plc | LSE:MANO | London | Ordinary Share | GB00BYWQCY12 | ORD 0.4P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 2.50 | 1.79% | 142.50 | 140.00 | 145.00 | 142.50 | 142.50 | 142.50 | 0.00 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Legal Services | 20.75M | -3.12M | -0.0714 | -19.96 | 62.36M |
From Apr 2021 to Apr 2024
TIDMMANO
RNS Number : 7661C
Manolete Partners PLC
23 June 2021
23 June 2021
MANOLETE PARTNERS PLC
("Manolete" or the "Company")
Audited results for the year ended 31 March 2021
Manolete (AIM:MANO), th e leading UK-listed insolvency litigation financing company, today announces its audited results for the year ended 31 March 2021.
Steven Cooklin, Chief Executive Officer, commented: "Despite the UK Government taking extraordinary action to temporarily suppress the number of insolvencies and levels of unemployment, we have delivered another set of strong financial and operating results. We are especially proud of delivering a 214% increase in our realised revenues to a record level of GBP24.4m and a 113% increase in Manolete's retained share of cash generated from completed cases."
"A record 198 new case investments were made in FY21 and a further record 135 cases were completed - displaying the fast and effective delivery of the Manolete business model. We continue to deliver outstanding investment returns, yielding an average Money Multiple of 2.7x and ROI of 168% on 388 completed cases since inception.
"We entered FY22 with GBP1.1m of gross cash and GBP12m of our HSBC Revolving Credit Facility (RCF) unutilised. We have now agreed a new RCF with HSBC for GBP25m over an initial three-year period to 1 July 2024, with an option to extend by a further year. The new RCF also offers the Company an additional GBP10m accordion, if ever required. This new RCF will provide Manolete with the financial firepower to continue investing in new insolvency litigation cases at a record pace in order to maximise returns to shareholders over the coming years.
"While the Government's emergency suppression of insolvencies is currently still in place, having been extended before, those Temporary Measures are currently due to end on 30 September 2021. However most commentators would agree that the Government's restrictions cannot continue indefinitely and interestingly in May 2021 Creditor Voluntary Liquidations (by far the most common type of company insolvency) were back to pre-Covid levels, even with those restrictions in place. The insolvency process will play a critical role in allocating capital and resources to truly sustainable businesses in the post-pandemic UK economy. With the widely reported large backlog of insolvency cases, we expect new case enquiries to increase over the foreseeable future and we will continue working hard to deliver outstanding returns to both the creditors of insolvent estates and our investors."
Financial (statutory and non-statutory) highlights:
-- Total revenues increased by 49% to GBP27.8m (FY20: GBP18.7m) -- Realised revenues increased by 214% to GBP24.4m (FY20: GBP7.8m) -- 88% of total revenues represented by realised revenues on fully completed cases (FY20: 42%) -- 75% of total gross profit generated from realised, completed cases (FY20: 24%)
-- EBIT decreased by 25% to GBP7.4m (FY20: GBP9.8m) reflecting lower level of unrealised profits due to exceptional Government measures, a more conservative assessment of the value of our in-process cases against the background of the pandemic and the full year effect of our expanded staff network
-- Profit before tax down 26% to GBP7.0m (FY20: GBP9.5m) -- Diluted earnings per share down 24% to 13 pence (FY20: 17 pence) -- Proposed final dividend of 1 pence per share
-- Cash generation: gross cash receipts from completed cases increased 61% to GBP12.2m (FY20: GBP7.6m)
-- The Company's retained share of gross cash receipts from completed cases (after all legal costs and payments to Insolvent Estates) increased by 113% to GBP6.8m (FY20: GBP3.2m)
-- Operating cashflows before new investments and corporation tax (non-statutory layout) increased to GBP2.8m in FY21 (FY20: cash outflow of GBP0.8m) hence cash inflows from completed cases exceeded payments to lawyers and IPs incurred on those cases and all overhead payments
-- Gross cash of GBP1.1m and borrowings of GBP8.0m as at 31 March 2021 and GBP12.0m unutilised funds available on Revolving Credit Facility with HSBC (same level as 31 March 2020)
Operational highlights:
-- 40% increase in new core investments in UK insolvency cases: 198 in FY21 (FY20: 141)
-- Ongoing delivery of realised returns: 135 case realisations in FY21 (on average 2.6 case realisations per week) with an average duration on those 135 cases of 11 months
-- ROI of 168% and Money Multiple of 2.7x from 388 completed cases since inception -- Average case duration across the full portfolio of 388 completed cases is 11 months -- 40% increase in live cases: 245 in process as at 31 March 2021 (175 as at 31 March 2020)
A copy of the annual report and accounts will be available on the Company's website shortly and will be posted to shareholders in due course.
For further information please contact:
Manolete Partners
Steven Cooklin (Chief Executive Officer) via Instinctif Partners Peel Hunt (NOMAD and Broker ) +44 (0)20 7418 8900
James Britton
Rishi Shah
Duncan Littlejohns
Instinctif Partners manolete@instinctif.com / +44 (0)20 7457 2020
Tim Linacre
Lewis Hill
George Peele
Chairman's Statement
Overview
I am pleased to report the Company has delivered a resilient performance in an unprecedented year with 198 new case investments in the year to 31 March 2021.
The Company's results reflect the strength, resilience and capabilities of the business through its expanding network of Insolvency Practitioners and insolvency lawyers throughout the UK.
Financial results
Revenues for the year to 31 March 2021 increased by 49% to GBP27.8m (FY20: GBP18.7m) and Profit before Tax was GBP7.0m compared to GBP9.5m in the prior year.
There were 135 case completions (FY20: 54 case completions) which is a record for the Company and these generated Gross Cash Receipts of GBP12.2m (FY20: GBP7.6m) (Net Cash receipts of GBP6.8m (FY20: GBP3.2m)) and realised revenue of GBP24.4m (FY20: GBP7.8m).
We agreed on 22 June 2021 a new GBP25m Banking Facility with HSBC to support the growth of the business. This Revolving Credit Facility is for three years and has the option to extend for another year together with a further approved but uncommitted GBP10m accordion. Details are set out in the CFO's report.
Strategy
We remain focused on strengthening the profile of Manolete and an important component to our strategy is to continue to build upon our network of established Insolvency Practitioner and insolvency lawyer contacts throughout the UK.
The Covid-19 pandemic resulted in the UK Government introducing the Corporate Insolvency and Governance Act 2020 ("temporary measures") to protect employment and businesses which has led to a fall in corporate insolvencies. These Temporary Measures are due to end on 30 September 2021 and have impacted our business particularly in the second half of the year.
Dividend
The Board has reviewed the dividend policy and is recommending a final dividend of 1.00p (FY20: 3.00p) per share giving a total dividend for the year of 2.17p (FY20: 4.17p) per share. Subject to the approval of shareholders at the Annual General Meeting on 21 September 2021, the dividend to Ordinary Shareholders will be payable on 7 October 2021 to those shareholders who are on the register of members at 10 September 2021.
Corporate Governance
The Board of directors is committed to good corporate governance. The Company has adopted the ten principles of the 2018 Version of the Corporate Governance Code as set out by the Quoted Companies Alliance. Our arrangements are further described in our Corporate Governance Statement on pages 25 to 28. During the year the Board undertook a formal board evaluation exercise. The Company is also committed to a robust Environmental, Social and Governance (ESG) Policy which is set out on its website.
The Audit Committee report on pages 29 to 30 and the Remuneration Committee report on pages 31 to 33 describe the remits and approaches of those committees to fulfilling their governance responsibilities. A statement on corporate governance is also provided on our website ( https://investors.manolete-partners.com/company-information/corporate-governance ).
People
On behalf of the Board and shareholders, I would like to thank our staff for their commitment and hard work during the year.
Board
This is my last statement as Non-Executive Chairman as I will be retiring as Chairman of the Board at the forthcoming AGM. We have separately announced today that Lord Leigh of Hurley has joined the Board as Chairman Designate.
Outlook
While we continue to trade profitably, the numbers of new cases have been negatively impacted by the Government's Temporary Measures. As the country moves out of lockdown, we expect the Government to end these measures and we anticipate a return to business as normal.
Overall, the business is very well-positioned in the insolvency litigation financing market for long-term profitable growth.
Peter Bertram
Non-Executive Chairman
22 June 2021
CEO's Statement
I am pleased to report on significant delivery to shareholders for the financial year ended 31 March 2021. The business reported a highly creditable performance despite the extraordinary measures taken by the UK Government to suppress the level of UK insolvencies, using temporary legislative measures contained within the Corporate Insolvency and Governance Act 2020 (the "Temporary Measures"), in order to protect businesses and employment during the Covid-19 pandemic.
Total UK corporate insolvencies in the year ended 31 March 2021 were 11,661 compared to 18,194 for the prior year: a decrease of 35.9%. Having been extended twice before, those Temporary Measures are currently due to end on 30 September 2021. However, most commentators would agree the Government's restrictions cannot continue indefinitely and, interestingly May 2021 Creditor Voluntary Liquidations (by far the most common type of company insolvency) were back to pre-Covid levels, even with those restrictions in place. Against this temporary, artificial UK insolvency market background the Company delivered resilient key performance indicators in FY21:
-- Invested in 198 new UK insolvency claims, an increase of 40% (FY20: 141); -- 135 cases were completed, an increase of 150% (FY20: 54); -- Realised revenues on completed cases were GBP24.4m, an increase of 214% (FY20: GBP7.8m); -- Gross cash receipts from completed cases were GBP12.2m, an increase of 61% (FY20: GBP7.6m);
-- The Company's retained share of gross cash receipts from completed cases (after all legal costs and payments to Insolvent Estates) was GBP6.8m, an increase of 113% (FY20: GBP3.2m);
-- Cash generated from operations (after all overheads but before new case investments and taxation) was GBP2.8m compared to an outflow of GBP0.7m in FY20; and
-- EBIT decreased to GBP7.4m, a decrease of 25% (FY20: GBP9.8m).
As at 31 March 2021, the Company had GBP12m committed but undrawn funds on its Revolving Credit Facility with HSBC, the same position as at 31 March 2020. We have now agreed on 22 June 2021 a new RCF for GBP25m over an initial three-year period to 1 July 2024, with an option to extend by a further year. The new RCF also offers the Company an additional approved but uncommitted GBP10m accordion, if ever required. The interest rate is a maximum 2.9% over SONIA.
The Company's operating and financial results were largely unaffected until September 2020. Since then, the number of new case enquiries and new case investments have slowed. The following graph shows the number of new signed cases per quarter. For Q1 and Q2 FY21, those quarters were strongly ahead of their comparative quarters for the prior year. The Temporary Measures (which were originally scheduled to end in September 2020) adversely impacted the performance of Q3 and Q4 of FY21, relative to Q1 and Q2 in FY21.
As cases completed at record levels throughout the year, our realised revenues and realised profits were strongly ahead of FY20. However, unrealised profits (on newly signed cases) were inevitably adversely impacted as the number of newly signed cases slowed in H2 of FY21. As at 31 March 2021, the Board has also carefully and conservatively reviewed the carrying value of all live cases in the light of the prevalent general UK economic conditions. The combined effect of these two factors resulted in unrealised revenues declining from GBP10.9m in FY20 to GBP3.4m in FY21. Overall, for FY21, 88% of total revenues (FY20: 42%) of GBP27.8m (FY20: GBP18.7m) and 75% of total gross profit (FY20: 24%) of GBP13.4m (FY20: GBP14.4m) were from realised completed cases - a strong testament to the Company's business model delivery.
Cash generation was very strong throughout FY21, particularly in the second half of FY21 which accounted for 66% of gross cash receipts from completed cases. Overall gross cash rose 61% to a record GBP12.2m for FY21. It should be noted that only 26% of those cash receipts came from cases completed in FY21 whereas 61% derived from cases that completed in FY20 (43%) and FY19 (18%), the balance of 13% coming from earlier case investment vintages. This highlights the cash latency in the Company's financial results: the large majority of the cash benefit of FY21's record realised revenues of GBP24.4m is yet to be reflected in the Company's cash reserves. The GBP12.2m of cash generated derived from 141 separate cases (FY20: GBP7.6m from 74 historical cases), which highlights the wide diversity and granularity of the Company's cash income.
The Cartel Cases continue to progress as expected and we note trials of similar related truck cartel cases are now scheduled in 2022. As Covid-19 has caused delays in the operation of the Competition and Appeals Tribunal, the Board has not adjusted the Fair Value of our Cartel Cases in FY21 which are valued at GBP7.1m (FY20: GBP7.1m).
The Company did not apply for any Covid-19 support, for example Government backed lending schemes or delayed tax settlements and no staff were put on furlough.
Investment Returns
Our investment track record, by vintage, continues to deliver outstanding results. All vintages, up to and including FY16, have been completed and FY17 has only one case remaining. FY18 cases are now 93% complete, FY19 88% complete and well over half of the FY20 cases. Manolete's model is characterised by short case durations, high ROIs (Return on Investment), exceptional Money Multiples and very high IRRs. We calculate case duration from the date we sign the investment agreement to the date the case is legally concluded. On average, cash collection takes around 12 months after legal completion.
Hot Features
Premium
Case vintages as at 31 May 2021
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Vintage No. No. % No. Open Closed Total Total Total IP Manolete Duration ROI MoM IRR
of completed Completed outstanding case case invested recovered gain share gain of
investments investments investments completed
cases
Year No No % No GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 GBP'000 Months % X %
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2010 3 3 100% 0 0 52 52 28 (24) 10 (35) 7.0m (67%) .3x 0%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2011 0 0 - 0 0 0 0 0 0 0 0 0.0m 0% .0x 0%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2012 8 8 100% 0 0 763 763 2,524 1,761 580 1,181 18.0m 155% 2.5x 236%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2013 10 10 100% 0 0 174 174 780 606 316 290 7.1m 166% 2.7x 281%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2014 42 42 100% 0 0 594 594 3,884 3,290 2,427 863 10.0m 145% 2.5x 424%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2015 39 39 100% 0 0 1,404 1,404 7,029 5,625 3,290 2,336 12.8m 166% 2.7x 526%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2016 36 36 100% 0 0 1,919 1,919 9,279 7,360 4,116 3,245 15.0m 169% 2.7x 181%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2017 31 30 97% 1 286 1,101 1,387 4,269 3,167 1,905 1,263 12.2m 115% 2.1x 554%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2018 29 27 93% 2 1,290 1,544 2,834 13,913 12,369 8,644 3,725 14.0m 241% 3.4x 484%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2019 59 52 88% 7 413 1,923 2,336 13,166 11,243 6,294 4,949 14.4m 257% 3.6x 152%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2020 141 86 61% 55 2,004 2,981 4,985 11,028 8,048 4,629 3,419 10.2m 115% 2.1x 220%
-------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------
2021 198 55 28% 143 2,489 946 3,435 3,619 2,673 1,425 1,248 5.0m 132% 2.3x 583% -------- ----------- --------- --------- ----------- ----------- ----------- -------- --------- ------- ------- -------- --------- ------- ------ ------ Total 596 388 65% 208 6,483 13,400 19,883 69,517 56,117 33,635 22,482 11.1m 168% 2.7x 132% ======== =========== ========= ========= =========== =========== =========== ======== ========= ======= ======= ======== ========= ======= ====== ====== (i) The vintages table excludes 22 cartel cases and is net of deductions for bad debt provisions (excluding ECL provisions). (ii) Ongoing cases includes partial realisations. (iii) The large case completion in FY21 is presented net of discounting. --------------------------------------------------------------------------------------------------------------------------------------------------------------------------
The more mature later vintages of FY18, FY19 and FY20 all have total case recoveries of over GBP10m per year and IRRs ranging from 152% to 484%. The FY21 vintage already shows 55 completed investments at an average duration of just 5.0 months per case.
Industry Recognition
On 9 December 2020, Manolete was voted Insolvency Litigation Funder of the Year for the fourth time in the last five years at the industry's prestigious Turnaround Recovery and Insolvency Awards. A great testament to the tremendous work of all the Company's employees.
Board Change
We have announced Peter Bertram will be retiring as Chairman of the Board at our forthcoming AGM, to be replaced by Lord Leigh of Hurley. Lord Leigh has now joined the Board and the intention is for him to transition to the Chairman's role at the forthcoming AGM later this year. I would like to record our great thanks to Peter for his expert guidance and leadership of the Board in the lead up to our IPO in 2018 and to our position as a well-established listed company.
COVID-19 Impact and Current Trading
The Board remains focused on the health, safety and well-being of all colleagues. Throughout the Covid-19 pandemic period, we have operated without interruption, none of our people were placed on furlough, and the Company has not taken advantage of any other Government support measures. Colleagues adapted well to remote working during lockdown periods and previous investments in our IT and operating infrastructure have proven to be invaluable.
Our work lends itself particularly well to the new environment: almost all cases come to us in electronic format; our settlement meetings (Mediations and Without Prejudice settlement meetings) easily transitioned to online video conference format and the Courts worked very hard to keep trials and hearings on track using online technologies.
At the time of writing, the UK continues to emerge cautiously but steadily from lockdown restrictions, particularly thanks to the seemingly effective vaccine roll-out programme. If that progress continues, we would expect the business operating environment, including the workings of the UK insolvency system, to resume normal operations in due course. As many commentators have noted, once the Temporary Measures end, there is likely to be a material increase in the number of UK insolvencies over an extended period of time, due to the backlog that has built up while those measures have been in force since June 2020. The UK's highly regarded insolvency system plays a vital role in allocating resources in the UK economy to sustainable and profitable companies and we expect it to play a vital role as Britain builds back better.
As many have predicted, the COVID-19 crisis is likely to lead to widespread global economic disruption. As we have said previously, we expect there will be an unavoidable knock-on effect for the UK economy and it is likely that this will lead to an increase in case referrals to Manolete in the months to come.
People and Stakeholders
I am enormously grateful to our in-house legal team and the finance and Net Worth Support team. It has been a very busy year, despite the challenges of COVID-19. All have performed admirably and are a great credit to the Company. My special thanks go to our Head of Legal, Mena Halton, who has onboarded and supervised a much larger UK-wide in-house legal team, on top of her day-to-day case work. The Company's excellent results are a great reflection of that work.
I would also like to record my thanks to the many Insolvency Practitioners and solicitors who refer cases to us. The majority of invested cases are from the same Insolvency Practitioner firms, and it is this recurring referral network that is the core engine of the Manolete business which has been built over the last 12 years.
I am pleased we continue to deliver on the growth plans, as we accelerate our growth through investing in more claims, accepting higher value cases and further developing our UK regional network.
Steven Cooklin
Chief Executive Officer
22 June 2021
CFO's Statement
I am pleased to give my review of the Company's audited results for the year to 31 March 2021.
Financial overview: 31 March 2021 31 March 2020 YoY growth Financial KPI's GBP000s GBP000s % ------------------------- -------------- -------------- ----------- Revenue 27,832 18,682 49 Gross profit 13,412 14,390 (7) Gross margin % 48.2% 77.0% EBIT 7,398 9,804 (25) EBIT % 27% 53% Profit after tax 5,700 7,615 (25) Investment valuation 37,508 32,415 16 Non-financial KPI's ------------------------- -------------- -------------- ----------- New cases 198 141 40 Completed cases* 135 54 150 Live cases at year end* 245 175 40 ------------------------- -------------- -------------- -----------
*including 7 partially completed cases & 22 cartel cases in FY21 (2 partial completions and 22 cartel cases in FY20).
During FY21, the Company completed a record 135 cases (FY20: 54) converting historical unrealised gains into realised revenue and profit. FY21 has seen a transition in the Company's revenue and margin mix, with realised revenue accounting for 88% of revenue (FY20: 42%) and 75% of gross profit.
This transition has driven improved operational cash generation before investment in cases and corporation tax to GBP2.8m (FY20: GBP(0.7)m) but has also resulted in the decline in gross margin from 77% in FY20 to 48% in FY21 as unrealised revenue flows through to gross profit at 100% margin. EBIT has decreased to GBP7.4m due to the increase in administrative costs by GBP1.4m primarily due to the full year impact of the lawyers recruited during FY20.
While the Company has completed a record number of cases, we have also signed 198 new cases (FY20: 141). However, due to the Government Covid-19 business support measures expected to remain in place until 30 September 2021, the sector has seen a notable decline in the level of insolvencies within the market during H2 which has translated into a reduced level of new case additions for Manolete in H2 FY21, 88 compared with 110 in H1 FY21 which has consequently impacted on unrealised revenue during FY21.
Revenue 31 March 2021 31 March 2020
GBP000s % GBP000s %
-------------------- -------------- --- -------------- ---
Realised revenue 24,427 88 7,782 42
Unrealised revenue 3,405 12 10,900 58
Revenue 27,832 18,682
==================== ============== === ============== ===
Despite the short-term drag on new cases, the Company's total revenues have increased significantly by 49% to GBP27.8m (FY20: GBP18.7m).
Realised revenue grew 214% to GBP24.4m (FY20: GBP7.8m) due to a record level of case completions, with 135 completions during the year including a significant case completion, which is explained in further detail below.
The decrease in unrealised revenue derives from a combination of the higher level of case completions (moving from unrealised revenue to realised revenue), a temporary slow-down in the insolvency market which reduced new case additions during H2 FY21 and the Board's reassessment of investment valuations in light of the pandemic which resulted in reduction of the Fair Value across ongoing live cases. Note 13 of the accounts provides a breakdown on the fair value movement.
Significant case completion
A significant case was completed during the year, for a settlement of GBP15m generating an undiscounted gross profit of GBP4.4m. The settlement is payable to Manolete over a 10 year period which is exceptional in nature when
compared with all other case settlements in the Company's history which typically settle within 12 months. Consequently, in accordance with IFRS 9, the gross proceeds of GBP15m have been discounted to revenue of GBP9.3m and gross profit of GBP2.8m in the FY21 accounts at an appropriate discount rate to recognise the significant financing component implicit in the arrangement. This represents an ROI of 1,592% before discounting and 1,019% after discounting. The impact of the settlement on the FY21 results is illustrated below.
Discounted large case All other cases 31 March 2021 31 March 2020
Profit and Loss GBP000s GBP000s GBP000s GBP000s
----------------------------- ---------------------- ---------------- -------------- --------------
Revenue 9,315 18,517 27,832 18,682
Cost of sales (6,496) (7,924) (14,420) (4,292)
Gross profit 2,819 10,593 13,412 14,390
Gross profit margin % 30% 57% 48% 77%
Balance Sheet
----------------------------- ---------------------- ---------------- -------------- --------------
Trade and other receivables 9,594 8,754 18,348 5,897
Trade and other payables 6,511 3,655 10,166 3,441
----------------------------- ---------------------- ---------------- -------------- --------------
Gross Profit 31 March 2021 31 March 2020
Gross Profit Gross Margin Gross Profit Gross Margin
GBP000s % GBP000s %
------------------------- ------------- ------------- ------------- -------------
Realised gross profit 10,007 40% 3,750 45%
Unrealised gross profit 3,405 100% 10,640 100%
Gross profit 13,412 48% 14,390 77%
------------------------- ------------- ------------- ------------- -------------
The decline in gross profit of 7% to GBP13.4m in FY21 (FY20: GBP14.4m) and the decrease in gross margin from 77% to 48% was a result of the increased proportion of realised revenue, for which revenue and related costs of sales are recognised, whereas, unrealised revenue (the Company's expected profit on each case) is recorded at 100% margin which is illustrated in the analysis of gross profit above. The large case completion in FY21 also impacted the gross margin for FY21.
Gross profit: H1 v H2
Reported gross profit in the six months to 30 September 2020 was GBP9.5m (71% of total gross profit), however, in the six months to 31 March 2021 was GBP3.9m (29% of total gross profit). Realised profits grew from GBP4.0m H1 to GBP6.0m in H2, but have been offset by a significant fall in unrealised profits from GBP5.4m in H1 to GBP(2.1)m in H2 as the impacts of the Covid-19 measures protecting businesses have started to filter through.
The ongoing Government temporary insolvency restrictions contained in the Corporate Insolvency and Governance Act 2020 which commenced in June 2020 and are due to largely expire in September 2021 have led to a decrease in the number of UK insolvencies since the start of the Covid-19 pandemic, which has seen the rate of the Company's new case additions slow from 110 in H1 to 88 in H2.
The directors have also carefully considered the investment valuations based on the challenging economic conditions and have adjusted case valuations where there has been evidence of defendant's having impaired asset positions which has impacted on total potential claim value in H2.
Administrative expenses 31 March 2021 31 March 2020 YoY growth
GBP000s GBP000s %
------------------------------------- -------------- -------------- -----------
Salaries and wages 3,486 2,573 35%
Bad debt expense 1,366 535 155%
Professional fees 533 433 23%
Marketing 168 513 (67)%
Other costs, including office costs 461 532 (13)%
Administrative costs 6,014 4,586 31%
===================================== ============== ============== ===========
Administrative expenses increased by 31% to GBP6.0m (FY20: GBP4.6m) but decreased as a proportion of gross revenue from 25% FY20 to 22% FY21. The increase in Administration expenses was primarily a result of increases in staff costs and bad debt expense.
Staff costs increased as the full year impact of previously recruited in-house lawyers and inflationary salary increases whilst headcount has increased marginally from 19 as at 31 March 2020 to 21 as at 31 March 2021.
In FY21, we have taken a cautious approach to providing against the small number of overdue receivables, particularly given the economic uncertainties due to the Covid-19 pandemic. We have increased our specific provision by GBP1.6m and we have also increased the level of our lifetime expected credit losses by GBP0.5m as shown in note 16. This has driven an increase in the bad debt expense in FY21 to GBP1.4m (FY20: GBP0.5m) which reflects the net credit risk to the Company after the gross provision against trade receivables is adjusted for a corresponding reduction in share of profits due to the Insolvency Practitioner.
Professional fees in FY21 include the services of two business development consultants (together a cost of GBP110k FY21) to further develop new cases.
Marketing costs decreased significantly by 67% in FY21, a direct result of Covid-19 limiting the ability to undertake business development activities.
Operating profit (Earnings Before Interest and Tax)
Operating profit decreased by 25% to GBP7.4m (FY20: GBP9.8m) with the operating margin decreasing to 27% (FY20: 53%). There were no exceptional items in FY21 or in FY20.
Finance costs
The Company agreed a GBP20m debt facility with HSBC in December 2018 to facilitate the growth of its case load in the future. The Company pays a 0.7% commitment fee on any unused facility with HSBC. As at 31 March 2021, GBP8.0m of the GBP20m HSBC facility has been drawn down, which is the same level of drawdown as at 31 March 2020.
During the year, the Company incurred GBP0.5m of finance costs (FY20: GBP0.4m). Loan interest amounted to GBP0.3m (FY20: GBP0.2m) and the remaining costs of GBP0.2m (FY20: GBP0.2m) comprised the amortisation charges of the costs of setting up the facility. The unamortised costs of GBP0.3m in the balance sheet are being amortised over the four-year life of the facility.
Profit before tax
Profit before tax has decreased by 26% to GBP7.0m (FY20: GBP9.5m). The Company's pre-tax profit margin has decreased from 51% to 25% in FY21.
Taxation
The Company's effective tax rate is 17.9%. The Company will discharge its corporation tax liabilities over the next few months.
Profit after tax
Profit after tax has decreased by 25% to GBP5.7m (FY20: GBP7.6m). The post-tax margin has decreased from 41% to 20%.
Earnings per share
As disclosed in Note 12, earnings per share decreased by 26% from 17 pence to 13 pence.
Balance sheet - Investment in Cases
The Company was managing 245 live case investments as at 31 March 2021, compared to 175 live cases as at 31 March 2020, a net increase of 70 cases, 40%. The total investment in cases amounted to GBP37.5m in FY21, an increase of 16% (FY20: GBP32.4m). Investment in cases are shown at fair value, based on the Company's estimate of the likely future realised gross profit, plus costs incurred.
Management, following discussion on a case-by-case basis with the in-house legal team, amend valuations of cases each month end to accurately reflect management's view of fair value. In addition, at the interim and final reporting periods, a sample of material valuations are corroborated with the external lawyers working on the case, who provide updated legal opinions as to the current status of the case. The Company does not capitalise any of its internal costs, these are fully expensed to the Statement of Comprehensive Income as incurred.
Operational cashflows 31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------------------------------------------------------------------- -------------- --------------
Gross cash receipts 12,203 7,569
IP share & legal costs on completed cases (5,376) (4,397)
Cashflows from completed cases 6,827 3,172
Overheads (4,040) (3,918)
-------------------------------------------------------------------------------------- -------------- --------------
Net cash generated / (used) in operations before investment in cases and corporation
tax 2,787 (746)
Corporation tax (1,923) (3,431)
Investment in cases (5,887) (4,098) -------------------------------------------------------------------------------------- -------------- -------------- Net cash used in operations (5,023) (8,275) -------------------------------------------------------------------------------------- -------------- -------------- % growth in case cash investments 44% 67% -------------------------------------------------------------------------------------- -------------- --------------
Gross cash receipts
Following the IPO in December 2018, the Company has experienced a period of significant investment with a total of 360 new cases signed. In FY21, while the level of cash investment in new cases continued to grow, the rate of growth slowed to 44% in FY21 compared with 67% in FY20 whilst there has been an acceleration in case completions which grew to 135 in FY21 (FY20: 54) and resultant cash collection.
This inflexion has driven strong growth in gross cash receipts from GBP7.6m in FY20 to GBP12.2m in FY21 (61%) and importantly, cash generated from operations before investment in cases and corporation tax has increased from a cash outflow of GBP(0.7)m in FY20 to a cash inflow of GBP2.8m in FY21 which has been reinvested into the portfolio.
Overheads & corporation tax
Excluding non-cash items (including bad debt expense), cash incurred on overheads remained broadly stable at around GBP4.0m. The Company has benefitted from savings on marketing and travel as a consequence of restrictions from the Covid-19 pandemic and improved operational leverage as revenue and case numbers have grown and the lawyers recruited during FY20 have been fully deployed.
Corporation tax paid during the year fell from GBP3.4m in FY20 to GBP1.9m as the Company settled one-off historical corporation tax liabilities of GBP2.6m with HMRC during FY20. As corporation tax is paid on unrealised as well as realised profits, the Company effectively pre-pays an element of its corporation tax liability. In FY21, the Company generated unrealised profits of GBP3.4m (FY20: GBP10.9m) of which corporation tax is payable at 19% totalling GBP0.6m (FY20: GBP2.1m).
Investment in cases
We have continued to invest heavily in our existing and new cases with total capital of GBP5.9m deployed during FY21 compared with GBP4.1m in FY20 which has been funded through cash receipts and our HSBC loan facility.
Working Capital
The GBP6.3m movement in working capital shown in the statutory cashflow (which excludes movements on prepayments and the property loan of GBP500k presented within other receivables in the notes to the financial statements) during FY21 is primarily due to a significant case completion (GBP3.1m) which is being settled over a 10 year period. Excluding the significant case completion which management view as an exceptional case, there was a GBP3.2m absorption into working capital due to the increased level of realised income during FY21. This increase in net trade receivables will generate cash in FY22. Debtor days on a countback basis increased from 150 in FY20 to 202 in FY21 mainly due to the settlement of the large case which is being settled over 10 years. Excluding the large case settlement, there has been a small decrease in debtor days to 142 (FY20: 150), albeit this has been limited by the Government-imposed moratorium on residential possession orders which has put a temporary halt on collection of several of our receivables. The moratorium has now been partially lifted as of 31 May 2021.
Large case All other cases 31 March 2021 31 March 2020
Net working capital GBP000s GBP000s GBP000s GBP000s
------------------------------- ----------- ---------------- -------------- --------------
Net working capital 3,084 5,124 8,208 1,946
Change in net working capital (3,084) (3,178) (6,262)
------------------------------- ----------- ---------------- -------------- --------------
DSO(1) basic 265 244
DSO(1) countback 142 202 150
------------------------------- ----------- ---------------- -------------- --------------
(1) Days sales outstanding
Debt Financing
The Company has drawn down GBP8.0m of its GBP20m HSBC loan facility and has continued to deploy loan capital to finance investment in cases. The Company held cash reserves of GBP1.1m as at 31 March 2021 which are available to both respond to any uncertainty over the Covid-19 pandemic and to deploy on new case investment. It also has GBP12m available of the GBP20m facility with HSBC and this facility and the cash reserves will be used to finance the growth of the case portfolio over the next few years. The Company has complied with its financial covenants during the year. A further drawdown of GBP2m has been made post year end.
We have agreed on 22 June 2021, a new RCF for GBP25m over an initial three-year period to 1 July 2024, with an option to extend by a further year. The new RCF also offers the Company an additional approved but uncommitted GBP10m accordion, if ever required. The interest rate is a maximum 2.9% over SONIA.
Mark Tavener
Chief Financial Officer
22 June 2021
Statement of Comprehensive Income
31 March 31 March
2021 2020
Note GBP'000s GBP'000s
--------------------------------------------------------------------------------------- ----- --------- ---------
Revenue 4 27,832 18,682
Cost of sales (14,420) (4,292)
--------------------------------------------------------------------------------------- ----- --------- ---------
Gross profit 13,412 14,390
Administrative expenses 8 (6,014) (4,586)
--------------------------------------------------------------------------------------- ----- --------- ---------
Operating profit 6 7,398 9,804
Finance income 9 50 89
Finance expense 9 (457) (437)
Profit before tax 6,991 9,456
Taxation 11 (1,291) (1,841)
Profit and total comprehensive income for the year attributable to the equity owners
of the
Company 5,700 7,615
======================================================================================= ===== ========= =========
Earnings per share attributable to equity owners of the Company
Basic (GBP per share) 12 GBP0.13 GBP0.17
Diluted (GBP per share) 12 GBP0.13 GBP0.17
--------------------------------------------------------------------------------------- ----- --------- ---------
The above results were derived from continuing operations.
The notes on pages 43 to 66 form part of these financial statements.
Statement of Financial Position
Company Number: 07660874 31 March 31 March
2021 2020
Note GBP000s GBP000s
---------------------------------- ------ --------- ---------
Non-current assets
Investments 13 7,136 7,136
Intangible assets 14 35 56
Trade and other receivables 16 10,660 443
Deferred tax asset 19 121 157
Right-of-use asset 15 257 -
---------------------------------- ------ --------- ---------
Total non-current assets 18,209 7,792
---------------------------------- ------ --------- ---------
Current assets
Investments 13 30,372 25,279
Trade and other receivables 16 7,688 5,454
Right-of-use asset 15 - 221
Cash and cash equivalents 17 1,144 8,371
---------------------------------- ------ --------- ---------
Total current assets 39,204 39,325
---------------------------------- ------ --------- ---------
Total assets 57,413 47,117
================================== ====== ========= =========
EQUITY AND LIABILITIES
Equity
Share capital 21 174 174
Share premium 22 4 4
Share based payment reserve 22 349 226
Special reserve 22 178 905
Retained earnings 22 38,223 33,613 ---------------------------------- ------ --------- --------- Total equity attributable to the equity owners of the company 38,928 34,922 ---------------------------------- ------ --------- --------- Non-current liabilities Trade and other payables 18 6,602 213 Borrowings 20 7,698 7,526 Lease liability 15/20 96 88 ---------------------------------- ------ --------- --------- Total non-current liabilities 14,396 7,827 ---------------------------------- ------ --------- --------- Current liabilities Trade and other payables 18 3,565 3,230 Current tax liabilities 11 335 1,005 Lease liability 15/20 189 133 Total current liabilities 4,089 4,368 ---------------------------------- ------ --------- --------- Total liabilities 18,485 12,195 ---------------------------------- ------ --------- --------- Total equity and liabilities 57,413 47,117 ================================== ====== ========= =========
The notes on pages 43 to 66 form part of these financial statements.
The financial statements were approved by the Board of Directors and authorised for issue on 22 June 2021.
Steven Cooklin
Chief Executive Officer
Statement of Changes in Equity
Attributable to equity owners of the
Company
----------------------------- -----------------------------------------------------------------
Share
Share Share based Special Retained Total
Capital Premium payment reserve Earnings Equity*
GBP'000s GBP'000s GBP'000s GBP'000s GBP'000s GBP'000s
----------------------------- --------- --------- --------- --------- ---------- ---------
As at 1 April 2019 174 4 67 3,157 24,613 28,015
Comprehensive income
Profit for the year - - - - 7,615 7,615
----------------------------- --------- --------- --------- --------- ---------- ---------
Transactions with owners
Dividends - - - - (867) (867)
Transfer in relation
to historical corporation
tax - - - (2,009) 2,009 -
Transfer in relation
to creditors paid - - - (243) 243 -
Share based payment expense - - 48 - - 48
Deferred tax on share-based
payments - - 111 - - 111
As at 31 March 2020 174 4 226 905 33,613 34,922
Comprehensive income
Profit for the year - - - - 5,700 5,700
----------------------------- --------- --------- --------- --------- ---------- ---------
Transactions with owners
Dividends - - - - (1,817) (1,817)
Transfer in relation
to creditors paid - - - (727) 727 -
Share based payment expense - - 122 - - 122
Deferred tax on share-based
payments - - 1 - - 1
As at 31 March 2021 174 4 349 178 38,223 38,928
----------------------------- --------- --------- --------- --------- ---------- ---------
*attributable to the equity owners of the Company.
The notes on pages 43 to 66 form part of these financial statements.
Statement of Cash Flows
31 March 31 March
2021 2020
Note GBP000s GBP000s
--------------------------------------------------------------------------------------- ----- --------- ---------
Profit before tax 6,991 9,456
Adjustments for other operating items:
Sale / (purchase) of property - 493
Other receivables 16 581 (500)
Adjustments for non-cash items 27 1,477 (9,008)
Operating cashflows before movements in working capital 9,049 441
Changes in working capital:
Net increase in trade and other receivables (12,952) (1,620)
Net increase in trade and other payables 6,690 433
--------------------------------------------------------------------------------------- ----- --------- ---------
Net cash generated / (used in) operations before corporation tax and investment in
cases 2,787 (746)
Corporation tax paid (1,923) (3,431)
Investment in cases 13 (5,887) (4,098)
--------------------------------------------------------------------------------------- ----- --------- ---------
Net cash used in operating activities (5,023) (8,275)
--------------------------------------------------------------------------------------- ----- --------- ---------
Cash flows from investing activities
Purchase of intangible assets 14 - (50)
Finance income received 9 6 35
--------------------------------------------------------------------------------------- ----- --------- ---------
Net cash generated / (used) in investing activities 6 (15)
--------------------------------------------------------------------------------------- ----- --------- ---------
Cash flows from financing activities
Proceeds from borrowings 20 - 8,000
Dividends paid 10 (1,817) (867)
Interest paid (240) (164)
Lease repayment 15 (153) -
Net cash (used) / generated from financing activities (2,210) 6,969
--------------------------------------------------------------------------------------- ----- --------- ---------
Net decrease in cash and cash equivalents (7,227) (1,321)
Cash and cash equivalents at the beginning of the year 8,371 9,692
--------------------------------------------------------------------------------------- ----- --------- ---------
Cash and cash equivalents at the end of the year 1,144 8,371
======================================================================================= ===== ========= =========
The notes on pages 43 to 66 form part of these financial statements.
Notes forming part of the Financial Statements
1. Company information
Manolete Partners PLC (the "Company") is a public company limited by shares incorporated in England and Wales. The Company is domiciled in England and its registered office is 2-4 Packhorse Road, Gerrards Cross, Buckinghamshire, SL9 7QE. The Company's ordinary shares are traded on the AIM Market.
The principal activity of the Company is that of acquiring and funding insolvency litigation cases.
2. Summary of significant accounting policies
The principal accounting policies applied in the preparation of these financial statements are set out below. The policies have been consistently applied to all the years presented, unless otherwise stated.
2.1 Basis of preparation
The above audited financial information does not constitute statutory financial statements as defined in section 434 of the Companies Act 2006. The above figures for the period ended 31 March 2021 have been extracted from the Company's financial statements which have been reported on by the Company's auditors and received an audit opinion which was unqualified. The Company's statutory financial statements for the year ended 31 March 2020 have been lodged with the Registrar of Companies. These financial statements received an audit report which was unqualified and did not include any reference to matters to which the auditors drew attention by way of emphasis without qualifying their report or a statement under section 498(2) or section 498(3) of the Companies Act 2006. The financial statements for the year ended 31 March 2021 will be dispatched to the shareholders and filed with the Registrar of Companies. The preliminary announcement was approved by the Board and authorised for issue on 22 June 2021.
Measurement bases
The financial statements have been prepared under the historical cost convention. Historical cost is generally based on the fair value of the consideration given in exchange for assets.
The preparation of the financial statements in compliance with adopted IFRS requires the use of certain critical accounting estimates and management judgements in applying the accounting policies. The significant estimates and judgements that have been made and their effect is disclosed in note 3.
2.2 Going concern
After making appropriate enquires, the directors of the Company have a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future and for at least one year from the date of the signed financial statements.
In particular, the Board considered the refinancing of the existing HSBC loan with a GBP25m revolving credit facility and a further approved but uncommitted GBP10m accordion which was signed on 22 June 2021 for a term until 1 July 2024 with a further 1 year extension along with the financial forecast of the business for an 16 month period from June 2021 to September 2022 which was discussed at January's Board meeting.
Furthermore, the Board has discussed the impact of Covid-19 on the business throughout the year. A reduced level of activity in the Insolvency market over the last 6 months, itself driven by unprecedented levels of Government support to failing businesses, has resulted in a lower level of new cases signed than would otherwise have been the case. The directors expect that the removal of Government support in the coming months is likely to lead to further insolvencies and related litigation cases.
On an operational basis, the business has been able to fully function remotely with our in-house lawyers meeting online with insolvency practitioners and external lawyers and continuing to progress cases. The Courts continue to function at first remotely but increasingly in person.
Based on this assessment, the directors are of the opinion that the Company has adequate financial resources to continue in operation and meet its liabilities as they fall due, for the foreseeable future as a minimum for a period of at least 12 months from the approval of these financial statements. Hence, the directors believe it is appropriate to adopt the going concern basis in preparing the financial statements.
For these reasons, they continue to adopt the going concern basis in preparing the Company's financial statements.
2.3 Functional and presentation currency
The financial information is presented in the functional currency, pounds sterling ("GBP") except where otherwise indicated.
2.4 New standards, amendments and interpretations
New and amended IFRS Standards that are effective for the current year:
-- Amendment to IFRS 16, 'Leases' - Covid-19 related rent concessions -- Amendments to IAS 1, Presentation of financial statements' on classification of liabilities
New and revised IFRS Standards in issue but not yet effective:
At the date of authorisation of these financial statements, the Company has not applied the following new and revised IFRS Standards that have been issued but are not yet effective:
-- Amendments to IAS 1 Classification of Liabilities as Current or Non-current
-- Amendments to IFRS 3 Reference to the Conceptual Framework Amendments to IAS 16 Property, Plant and Equipment-Proceeds before Intended Use
-- Amendments to IAS 37 Onerous Contracts - Cost of Fulfilling a Contract Annual Improvements to IFRS Standards 2018-2020 Cycle
-- Amendments to IFRS 1 First-time Adoption of International Financial Reporting Standards, IFRS 9 Financial Instruments, and IFRS 16 Leases.
The directors do not expect that the adoption of the Standards listed above will have a material impact on the financial statements of the Company in future periods.
2.5 Revenue recognition
Revenue comprises two elements: the movement in fair value of investments and realised consideration.
Realised consideration occurs when a case is settled, or a Court judgement received. This is an agreed upon and documented figure.
The movement in the fair value of investments is recognised as Unrealised gains within Revenue. This is management's assessment of the increase or decrease in valuation of an open case, the inclusion of value for a new case and the removal of the fair value of a completed case. These valuations are estimated following the progress of a case towards completion and also reflect the judgement of the legal team working on the case (see Note 3. Significant Judgements and Estimates). Hence, unrealised revenue is the movement in the fair value of the investments in open cases over a period of time.
When a case is completed the carrying value is a deduction to unrealised income and the actual settlement value is recorded as realised revenue.
Revenue recognition differs between a purchased case, where full recognition of the settlement is recognised as revenue (including the insolvent estate's share) and a funded case where only the Company's share of a settlement is recognised as revenue. This differing treatment arises because the Company owns the rights to the purchased case.
As revenue relates entirely to financing arrangements, revenue is recognised under the classification and measurement provisions of IFRS 9.
2.6 Finance expense and income
Finance expense
Finance expense comprises interest on bank loans and other interest payable. Interest on bank loans and other interest is charged to the statement of comprehensive income over the term of the debt using the effective interest rate method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.
Finance income
Finance income comprises interest receivable on funds invested and other interest receivable. Interest income is recognised in profit or loss as it accrues using the effective interest method.
2.7 Employee benefits: Pension obligations
The Company operates a defined contribution plan. A defined contribution plan is a pension plan under which the Company pays fixed contributions into a separate entity. The Company has no legal or constructive obligations to pay further contributions if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.
The Company has no further payment obligations once the contributions have been paid. The contributions are recognised as employee benefit expense when they are due. Prepaid contributions are recognised as an asset to the extent that a cash refund or a reduction in the future payments is available.
2.8 Intangible assets
Intangible assets are measured at cost and are amortised on a straight-line basis over their estimated useful lives. Amortisation is charged within administrative expenses in the statement of comprehensive income so as to write off the cost of assets over their estimated useful lives, on the following basis:
Website development costs: 33.3% of cost
2.9 Financial assets
Classification
The Company classifies its financial assets at amortised cost or fair value through profit or loss. Financial assets do not comprise prepayments. Management determines the classification of its financial assets at initial recognition.
Financial assets at amortised cost
The Company's financial assets held at amortised cost comprise trade and other receivables and cash and cash equivalents in the statement of financial position.
These assets are non-derivative financial assets with fixed or determinable payments that are not quoted in an active market. They arise principally through the provision of goods and services to customers (e.g. trade receivables), but also incorporate other types of contractual monetary asset. They are initially recognised at fair value plus transaction costs that are directly attributable to their acquisition or issue and are subsequently carried at amortised cost using the effective interest method, less provision for impairment.
Impairment of financial assets
Impairment provisions are recognised when there is objective evidence (such as significant financial difficulties on the part of the counterparty or default or significant delay in payment) that the Company will be unable to collect all of the amounts due under the terms receivable, the amount of such a provision being the difference between the net carrying amount and the present value of the future expected cash flows associated with the impaired asset.
Impairment provisions for trade receivables are recognised specifically against receivables where Management have identified default or delays to payments in addition to the simplified approach within IFRS 9 using lifetime expected credit losses. The Company applies the simplified approach in providing for expected credit losses under IFRS 9 which allows the use of the lifetime expected credit loss provision for all trade receivables. In measuring the expected credit losses, trade receivables have been stratified by settlement type and days past due. Expected lifetime expected credit loss rates are based on the payment profiles of sales from January 2019 (post IPO). For trade receivables which are reported net, such provisions are recorded in a separate provision account with the loss being recognised within administrative expenses in the statement of comprehensive income. On confirmation that the trade receivable will not be collectable , the gross carrying value of the asset is written off against the associated provision.
Investments
Investments in cases are categorised at fair value through profit or loss. Fair values are determined on the specifics of each investment and will typically change upon an investment progressing through a key stage in the litigation or arbitration process in a manner that, in the directors' opinion, would result in a third party being prepared to pay an amount different to the original sum invested for the Company's rights in connection with the investment. Positive material progression of an investment will give rise to an increase in fair value and an adverse progression a decrease. Management identifies and selects a number of material case valuations for external opinion. As such this year the valuation of a sample of material investments was underpinned by an external legal opinion, which confirms the directors' valuation.
Valuation of investments
Determining the value of purchased and funded litigation requires an estimation of the value of such assets upon acquisition and at each reporting date. The future income generation of such litigation is estimated from known information and the opinion of external senior specialist counsel and solicitors. Valuations of each case, at the balance sheet date, are therefore arrived at by the directors, considering counsel's, or external lawyer's, assessment of the chances of a successful outcome, the state of progress of the matter through the legal system and the directors' assessment of all other risks specific to the case.
Contract assets are initially recognised in respect of earned interest revenue earned on completed cases but where the settlement will be paid to the Company over a significant period of time (i.e. there is a significant financing component implicit in the transaction).
2.10 Financial Liabilities
The Company classifies its financial liabilities in the category of financial liabilities at amortised cost. All financial liabilities are recognised in the statement of financial position when the Company becomes a party to the contractual provision of the instrument. Trade and other payables and borrowings are included in this category.
Borrowings
Borrowings are recognised initially at fair value, net of transaction costs incurred. Borrowings are subsequently carried at amortised cost; any difference between the proceeds (net of transaction costs) and the redemption value is recognised in the income statement over the period of the borrowings using the effective interest method.
Borrowings are de-recognised from the balance sheet when the obligation specified in the contract is discharged, is cancelled or expires. The difference between the carrying amount of a financial liability that has been extinguished or transferred to another party and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognised in profit or loss as other operating income or finance costs.
Borrowings are classified as current liabilities unless the Company has an unconditional right to defer settlement of the liability for at least 12 months after the reporting period.
Trade and other payables
Trade and other payables are initially recognised at fair value and subsequently measured at amortised cost. Accounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities.
Lease liabilities
A lease liability is recognised at the commencement date of a lease. The lease liability is initially recognised at the present value of the lease payments to be made over the term of the lease, discounted using the interest rate implicit in the lease or, if that rate cannot be readily determined, the Company's incremental borrowing rate. Lease payments comprise of fixed payments less any lease incentives received.
Lease liabilities are measured at amortised cost using the effective interest method. The carrying amounts are remeasured if there is a change in the following: future lease payments arising from a change in an index or a rate used; residual guarantee; lease term; certainty of a purchase option and termination penalties. When a lease liability is remeasured, an adjustment is made to the corresponding right-of-use asset, or to profit or loss if the carrying amount of the right-of-use asset is fully written down.
Contract liabilities
Contract liabilities represent the Company's obligation to transfer goods or services to a customer and are recognised when a customer pays consideration, or when the Company recognises a receivable to reflect its unconditional right to consideration (whichever is earlier) before the consolidated entity has transferred the goods or services to the customer.
2.11 Provisions
A provision is recognised in the balance sheet when the Company has a present legal or constructive obligation as a result of a past event, and it is probable that an outflow of economic benefits will be required to settle the obligation. If the effect is material, provisions are determined by discounting the expected future cash flows at a pre-tax rate that reflects current market assessments of the time value of money and, when appropriate, the risks specific to the liability. The increase in the provision due to the passage of time is recognised in finance costs.
2.12 Share capital
Ordinary shares are classified as equity. There is one class of ordinary share in issue, as detailed in note 21. Incremental costs directly attributable to the issue of new shares are shown in share premium as a deduction from the proceeds, net of tax.
2.13 Income tax
Income tax for the years presented comprises current and deferred tax. Income tax is recognised in profit or loss except to the extent that it relates to items recognised directly in equity, in which case it is recognised in equity
Deferred income tax is recognised on temporary differences arising between the tax bases of assets and liabilities and their carrying amounts.
Temporary differences are not recognised if they arise from a) the initial recognition of goodwill, and b) for the initial recognition of other assets or liabilities in a transaction other than a business combination that at the time of the transaction affects neither accounting nor taxable profit or loss. The amount of deferred tax provided is based on the expected manner of realisation or settlement of the carrying amount of assets and liabilities, using tax rates enacted or substantively enacted at the balance sheet date.
Deferred income tax assets and liabilities are offset when there is a legally enforceable right to offset current tax assets against current tax liabilities and when the deferred income taxes assets and liabilities relate to income taxes levied by the same taxation authority on either the taxable entity or different taxable entities where there is an intention to settle the balances on a net basis.
2.14 Share-based payments
Equity-settled share-based compensation benefits are provided to employees.
Equity-settled transactions are awards of shares, or options over shares, that are provided to employees in exchange for the rendering of services.
The cost of equity-settled transactions are measured at fair value on grant date. Fair value is independently determined using the Black-Scholes option pricing model that takes into account the exercise price, the term of the option, the impact of dilution, the share price at grant date and expected price volatility of the underlying share, the expected dividend yield and the risk free interest rate for the term of the option, together with non-vesting conditions that do not determine whether the consolidated entity receives the services that entitle the employees to receive payment. No account is taken of any other vesting conditions.
The cost of equity-settled transactions are recognised as an expense with a corresponding increase in equity over the vesting period. The cumulative charge to profit or loss is calculated based on the grant date fair value of the award, the best estimate of the number of awards that are likely to vest and the expired portion of the vesting period. The amount recognised in profit or loss for the period is the cumulative amount calculated at each reporting date less amounts already recognised in previous periods.
2.15 Right-of-use assets
A right-of-use asset is recognised at the commencement date of a lease. The right-of-use asset is measured at cost, which comprises the initial amount of the lease liability, adjusted for, as applicable, any lease payments made at or before the commencement date , net of any lease incentives received, any initial direct costs incurred, and, except where included in the cost of inventories, an estimate of costs expected to be incurred for dismantling and removing the underlying asset, and restoring the site or asset.
Right-of-use assets are depreciated on a straight-line basis over the unexpired period of the lease or the estimated useful life of the asset, whichever is the shorter. Right-of-use assets are subject to impairment or adjusted for any remeasurement of lease liabilities. Depreciation is charged to administrative expenses in the Statement of Comprehensive Income.
2.16 Earnings per share
Basic Earnings Per Share
Basic earnings per share is calculated by dividing the profit attributable to the owners of the Company by the weighted average number of ordinary shares outstanding during the financial year.
Diluted Earnings Per Share
Diluted earnings per share adjusts the figures used in the determination of basic earnings per share to take into account the after income tax effect of interest and other financing costs associated with dilutive potential ordinary shares and the weighted average number of shares assumed to have been issued for no consideration in relation to dilutive potential ordinary shares.
2.17 Dividends
Dividends are recognised when declared during the financial year and no longer at the discretion of the Company.
3. Significant judgements and estimates
The preparation of the Company's financial statements under IFRS requires the directors to make estimates and assumptions that affect the reported amounts of assets and liabilities at the statement of financial position date, amounts reported for revenues and expenses during the year, and the disclosure of contingent liabilities, at the reporting date. However, uncertainty about these assumptions and estimates could result in outcomes that could require a material adjustment to the carrying amount of the assets or liability affected in the future.
Estimates and judgements are continually evaluated and are based on historical experiences and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
The Company makes estimates and assumptions concerning the future. The resulting accounting estimates will, by definition, seldom equal the related actual results. The estimates and assumptions that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are detailed below.
Valuation of investments
Investments in cases are categorised as fair value through Profit or Loss. Fair values are determined on the specifics of each investment and will typically change upon an investment progressing through a key stage in the litigation or arbitration process in a manner that, in the directors' opinion, would result in a third party being prepared to pay an amount different to the original sum invested for the Company's rights in connection with the investment. Positive material progression of an investment will give rise to an increase in fair value and an adverse progression a decrease.
The key stages that an individual case passes through typically includes: initial review on whether to make a purchase or funding offer, correspondence from the Company in-house lawyer, usually via externally retained solicitors, to the opposing party notifying them of the Company's assignment or funding of the claim, a fully particularised Letter Before Action and an invitation to without prejudice settlement meetings or mediation, if the opposing party does not respond then legal proceedings are issued. Further evidence may be gathered to support the claim. Eventually a court process may be entered into. The progress of a case feeds into the director's valuation of that case each month, as set out below.
In accordance with IFRS 9 and IFRS 13, the Company is required to recognise live case investments at fair value at the half year and year end reporting periods, at 30 September and 31 March each year.
The Company undertakes the following steps:
-- On a weekly basis, the internal legal team report developments into the Investment Committee on a case-by-case basis in writing. Full team meetings then take place on a monthly basis to review progress on all live cases, on a case-by-case basis over several hours;
-- On a monthly basis, the directors adjust case fair values depending upon objective case developments, for instance: an offer to settle, mediation agreed, positive or negative legal advice. These adjustments to fair value may be an increase or decrease in value or no change required; and
-- At reporting period ends, a sample of open case investments is selected for which written assessments are obtained from external solicitors or primary counsel working on the case on behalf of the Company.
In all cases, a headline valuation is the starting point of a valuation from which a discount is applied to reflect legal advice obtained, strength of defendant's case, the likely amount a defendant might be able to pay to settle the case, progress of the case through the legal process and settlement offers.
Movements in fair value on investments in cases are included within revenue in the Statement of Comprehensive Income. Fair value gains or losses are unrealised until a final outcome or stage is reached. At the year-end there were 245 open cases, of these 194 had a valuation of less than GBP100k. These cases are not expected to have an individually material impact on the business when they are settled. The remaining 51 cases make up GBP26.4m of the Investments and are material to the business, the significant judgements and estimates in their valuations at the balance sheet date were as follows:
1. Judgements:
1.1 The amount that cases are discounted to recognise cases being settled before they are taken to Court, based on the facts of each case and management's judgement of the likely outcome.
1.2 Litigation is inherently uncertain. The Company seeks to mitigate its risk by: rejecting the majority of cases referred to it because the merits of the claim are considered weak or the defendant is considered not to have sufficient net worth and seeking to settle cases as early as possible. Nevertheless, the risk and uncertainty can never be completely removed. The key inputs are: the headline claim value, the likely settlement value, the opposing party's ability to pay and the likely costs in achieving the judgement. These inputs are inter-related to an extent.
1.3 Excluding the large case completion in FY21, the Company does not consider there to be any significant concentration of risk within either trade or other receivables.
1.4 The Company accrues for future legal costs on the basis that cases will be settled before trial which is how the vast majority of the 388 cases completed to date have been settled. When it becomes clear a case will progress all the way to trial the additional costs are accrued at this point on a case-by-case basis.
2. Estimates:
2.1 All cases will be subject to the internal key stages and regular fair value review processes as described above. For the avoidance of doubt, the fair value review requires an estimate to be made by senior management based upon the facts and progress of the case and their experience. For a sample selected by Management and reviewed by the external auditors, an external opinion is requested from counsel or a solicitor who is working on the case which provides an independent description of the merits of the case.
These assessments include various assumptions that could change over time and lead to different assessments over the next 12 months.
2.2 Future legal costs have been estimated on the estimated time the case will take to complete, ranging between 3 to 24 months (excluding the Cartel cases) and whether it will go to Court. Future results could be materially impacted if these original estimates change either positively or negatively.
2.3 Recovery of debts is based on the Company's ability to recover assets owned by the counterparty. Prior to case acceptance, a net worth review of the defendant is undertaken to ensure that they own sufficient assets to support the claim value. Cases that are settled without going to Court agree a repayment schedule, whilst those that result in Court cases are less predictable in terms of full recovery.
2.4 The valuations assume that there is no recovery for interest and costs. If cases go to Court and result in a judgement in the Company's favour, it is likely that the Company will be awarded interest and costs.
Sensitivity analysis has not been included in the financial statements, due to the vast amount of inputs and number of variables which are inherently specific to each case, making it impossible to provide meaningful data. Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, reasonable and robust, because of the inherent uncertainty of valuation, it is reasonably possible, on the basis of existing knowledge, that outcomes within the next financial year that are different from the assumptions could require a material adjustment to the carrying amount of the GBP37.5m of investments disclosed in the balance sheet. However, as an indication we note that a 10% increase/(decrease) in the fair value of our top 20 cases (including Cartel cases) would result in an increase/(decrease) in the fair value investment of +/- GBP2.13m.
Recoverability of trade receivables
The Company's business model involves the provision of services for credit. The Company normally receives payment for services it has provided once a claim has been pursued and settled or decided in Court. The average time from taking on a case to settlement is c.12 months although this can vary significantly from case to case. As part of the settlement agreement, the timing of payment of the award by the defendant to the Company is agreed, this is a legally binding document. Settlements can be received in full on the day of settlement or (at Management's discretion) paid in instalments over a defined settlement plan.
As such, Management applies a number of estimates and judgements in the recording of trade receivables, for example: in relation to default judgements Management assess the likely recoverability and do not necessarily recognise the full judgement; Management also assessed recoverability of receivables in light of the Covid pandemic and its impact on certain debtors to manage repayments; which further informed our expected credit loss.
The Company applies the simplified approach in providing for expected credit losses under IFRS 9 which allows the use of the lifetime expected credit loss provision for all trade receivables. In measuring the expected credit losses, trade receivables have been stratified by settlement type and days past due. Expected lifetime expected credit loss rates are based on the payment profiles of sales from January 2019 (post IPO). The Company attempts to assess the probability of credit losses but seeks to mitigate its credit risk by undertaking rigorous net worth checks before taking on a case. Occasionally, credit defaults do sometimes occur when counterparties default on an agreed settlement, payable by instalments.
There is a concentration risk in relation to the trade receivable of GBP9.6m in relation to the large case completion in FY21. Repayments to date have been made according to the agreed schedule. Based on management's assessment of the receivable no provision has been recognised against this balance.
Recovery of receivables is closely monitored by Management and action, where appropriate, will be taken to pursue any overdue payments. The Company seeks to obtain charging orders over the property of trade receivables as security. The receivables' ageing analysis is also evaluated on a regular basis for potential doubtful debts. It is the directors' opinion that no further provision for doubtful debts is required.
4. Segmental reporting
During the year ended 31 March 2021, revenue was derived from cases funded on behalf of the insolvent estate and cases purchased from the insolvent estate, which are wholly undertaken within the UK. Where cases are funded, upon conclusion, the Company has the right to its share of revenue; whereas for purchased cases, it has the right to receive all revenue, from which a payment to the insolvent estate is made. Revenues arising from funded cases and purchased cases are considered one business segment and are considered to be the one principal activity of the Company. All revenues derive from continuing operations and are not seasonal in nature.
Net realised gains on investments in cases represents realised revenue on completed cases.
Fair value movements includes the increase / (decrease) in fair value of open cases, the removal of the carrying fair value of realised cases (in the period when a case is completed and recognised as realised revenue) and the addition of the fair value of new cases.
31 March 2021 31 March 2020
GBP000s GBP000s
--------------------------------------------------------- -------------- --------------
Net realised gains on investments in cases 24,427 7,782
Fair value movements (net of transfers to realisations) 3,405 10,900
--------------------------------------------------------- -------------- --------------
27,832 18,682
========================================================= ============== ==============
Included within the net realised gains on investments in cases above are GBP434k (FY20: Nil) in relation to the unwinding of the discount of amounts due on a significant debtor.
31 March 31 March
2021 2020
GBP000s GBP000s
----------------- --------- ---------
Arising from:
Purchased cases 24,486 13,335
Funded cases 3,346 5,347
27,832 18,682
================= ========= =========
5. Directors and employees
Staff costs for the Company during the year:
31 March 2021 31 March 2020
Staff costs (including directors): GBP000s GBP000s
------------------------------------ -------------- --------------
Wages and salaries 2,886 2,222
Social security costs 335 236
Other pension costs and benefits 265 115
------------------------------------ -------------- --------------
Total staff costs 3,486 2,573
==================================== ============== ==============
The average monthly number of employees (including executive and non-executive directors) employed by activity was:
31 March 2021 31 March 2020
No. No.
----------------------------------------- -------------- --------------
Directors (executive and non-executive) 5 5
Management and administration 16 14
----------------------------------------- -------------- --------------
Average headcount 21 19
========================================= ============== ==============
The aggregate amounts charged in the accounts for key management personnel (including employer's National Insurance contributions), being the directors of the Company, were as follows:
31 March 31 March 2020
Directors' emoluments: 2021
GBP000s GBP000s
--------------------------------------------------------------------------- --------- --------------
Salaries and fees (including employer's National Insurance contributions) 865 822
Other pension costs and benefits 20 20
--------------------------------------------------------------------------- --------- --------------
Total 885 842
=========================================================================== ========= ==============
Director's remuneration is detailed in the Remuneration report.
31 March 2021 31 March 2020
GBP000s GBP000s
---------------------------------- -------------- --------------
Highest paid director:
Salaries and fees 404 335
Other pension costs and benefits 10 14
---------------------------------- -------------- --------------
Total 414 349
================================== ============== ==============
Management consider the directors to be the key management personnel.
6. Operating profit
Is stated after charging / (crediting):
31 March 2021 31 March 2020
GBP000s GBP000s
---------------------------------------- -------------- --------------
Bad debt expenses 1,366 535
Share based payments 122 63
Depreciation of right-of-use-asset 140 125
Amortisation of intangible assets 21 13
Profit on sale of residential property - (7)
======================================== ============== ==============
7. Auditor remuneration
Amounts payable to RSM UK Audit LLP and its related entities in respect of both audit and non-audit services are set out below.
31 March 2021 31 March 2020
GBP000s GBP000s
------------------------------------------------------------------------------------ -------------- --------------
Fee payable to Company's auditor and its associates for the statutory audit of the
Company's
financial statements 65 62
Fees payable to Company's auditor and its associates for other services:
Interim agreed upon procedures 9 10
Other taxation services - 15
------------------------------------------------------------------------------------ -------------- --------------
Total 74 87
==================================================================================== ============== ==============
Details of the Company's use of the Auditors for non-audit services, the reasons why the Auditors were used rather than another supplier and how the Auditors' independence and objectivity was safeguarded are set out in the Audit Committee Report on pages 29 to 30.
8. Analysis of expenses by nature
Internal legal costs are included within administrative expenses whereas external legal costs are either capitalised as Investments for open cases or recognised as cost of sales on completed cases.
The breakdown by nature of administrative expenses is as follows:
31 March 2021 31 March 2020
GBP000s GBP000s
Staff Costs, including pension and healthcare costs 3,486 2,573
Bad debts including expected credit losses 1,366 535
Professional fees 533 433
Marketing costs 168 513
Other costs, including office costs 461 532
----------------------------------------------------- -------------- --------------
Total administrative expenses 6,014 4,586
===================================================== ============== ==============
9. Finance income and finance expense
31 March 2021 31 March 2020
GBP000s GBP000s
---------------------- -------------- --------------
Bank interest 6 39
Other loan interest 44 50
---------------------- -------------- --------------
Total finance income 50 89
====================== ============== ==============
31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------- -------------- --------------
Lease liability interest 48 57
Other loan interest 218 229
Bank loan charges 191 151
Total finance expense 457 437
========================== ============== ==============
10. Dividends
Dividends paid during the financial year were as follows.
31 March 2021 31 March 2020
Declared during the year GBP000s GBP000s
------------------------------------------------------------------------------------ -------------- --------------
Final dividend for the year ended 31 March 2020 of 3.00p per share, paid in
September 2020
(September 2019: 1.49p) 1,307 649
Interim dividend for the year ended 31 March 2021 of 1.17p per share, paid in
December 2020
(December 2019: 0.5p) 510 218
------------------------------------------------------------------------------------ -------------- --------------
Total dividends paid during FY21 1,817 867
==================================================================================== ============== ==============
Proposed after the end of year and not recognised as a liability
------------------------------------------------------------------------------------ -------------- --------------
Final dividend for the year ended 31 March 2021: 1.00p per share (31 March 2020:
3.00p per
share) 436 1,307
==================================================================================== ============== ==============
11. Taxation
31 March 31 March
2021 2020
Analysis of charge in year GBP000s GBP000s
Current tax charge on profits for the
year 1,353 1,841
Adjustments in respect of prior periods (99) -
----------------------------------------- --------- ---------
Total current tax charge 1,254 1,841
Total deferred tax charge 37 -
----------------------------------------- --------- ---------
Tax on profit on ordinary activities 1,291 1,841
========================================= ========= =========
T he tax charge for the year differs from the standard rate of corporation tax in the UK of 19% (2020: 19%). The differences are explained below.
31 March 2021 31 March 2020
GBP000s GBP000s
------------------------------------------------------------------------------------ -------------- --------------
Profit on ordinary activities before tax 6,991 9,456
------------------------------------------------------------------------------------ -------------- --------------
Profit on ordinary activities multiplied by the rate of corporation tax in the UK
as above 1,328 1,797
Effects of:
Expenses not deductible 24 44
Adjustments to current tax in respect of previous periods (99) -
Deferred tax charged directly to equity 1 -
Temporary differences not recognised in the computation 37 -
------------------------------------------------------------------------------------ -------------- --------------
Tax charge for the period 1,291 1,841
==================================================================================== ============== ==============
12. Earnings Per Share
The Basic Earnings Per Share is calculated by dividing the profit attributable to ordinary equity holders by the weighted average number of ordinary shares outstanding during the year. Diluted Earnings Per Share is calculated by dividing the profit after tax by the weighted average number of shares in issue during the year, adjusted for potentially dilutive share options. The following reflects the income and share data used in the earnings per share calculation:
31 March 2021 31 March 2020
GBP000s GBP000s
--------------------------------------------------------------------- -------------- --------------
Profit for the period attributable to equity holders of the Company 5,700 7,615
Weighted average number of ordinary shares 43,571,425 43,571,425
--------------------------------------------------------------------- -------------- --------------
Basic Earnings Per Share GBP0.13 GBP0.17
===================================================================== ============== ==============
Basic Earnings Per Share is based on the profit for the year attributable to the equity holders of the Company divided by the weighted average number of ordinary shares during the period.
31 March 2021 31 March 2020
GBP000s GBP000s
--------------------------------------------------------------------- -------------- --------------
Profit for the period attributable to equity holders of the Company 5,700 7,615
Diluted weighted average number of ordinary shares 44,543,718 44,318,539
--------------------------------------------------------------------- -------------- --------------
Diluted Earnings Per Share GBP0.13 GBP0.17
===================================================================== ============== ==============
Reconciliation of number of shares and diluted shares at year end:
31 March 2021 31 March 2020
GBP000s GBP000s
------------------------------------------------------------------ -------------- --------------
Weighted average number of shares for Basic Earnings Per Share 43,571,425 43,571,425
Adjustments for calculation of Diluted Earnings Per Share:
Options over ordinary shares 973,293 747,114
------------------------------------------------------------------ -------------- --------------
Weighted average number of shares for Diluted Earnings Per Share 44,543,718 44,318,539
------------------------------------------------------------------ -------------- --------------
The earnings per share is diluted by options over ordinary shares, as detailed in note 23.
13. Investments
Non-current investments and current asset investments comprise the costs incurred in bringing funded and purchased cases to the position that they have reached at the balance sheet date. In addition, where an event has occurred that causes the directors to revalue the amount invested, a fair value adjustment is made by the directors based on Counsel's and the directors' opinion, which can either be positive or negative (see Note 3.2 on accounting estimates).
31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------------------------------------- -------------- --------------
As at 1 April 2020 32,415 18,197
Additions 5,887 4,917
Realisations (4,199) (1,599)
Fair value movement (net of transfers to realisations) 3,405 10,900
-------------------------------------------------------- -------------- --------------
As at 31 March 2021 37,508 32,415
-------------------------------------------------------- -------------- --------------
Current 30,372 25,279
Non-current 7,136 7,136
-------------------------------------------------------- -------------- --------------
As at 31 March 2021 37,508 32,415
======================================================== ============== ==============
Analysis of fair value movements 31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------------------------------------- -------------- --------------
New case investments 12,398 8,581
Increase in existing case fair value 1,865 3,729
Decrease in existing case fair value (1,356) (1,412)
Case completions (9,502) (2,001)
Cartel cases - 2,003
-------------------------------------------------------- -------------- --------------
Fair value movement (net of transfers to realisations) 3,405 10,900
======================================================== ============== ==============
14. Intangible assets
Intangible assets comprised the costs of developing the Company's website. The website developments costs are amortised over the useful life of the website, which is estimated to be three years.
Website development costs 31 March 2021 31 March 2020
GBP000s GBP000s
As at 1 April 2020 56 6
Additions - 63
Amortisation charge (21) (13)
--------------------------- -------------- --------------
As at 31 March 2021 35 56
=========================== ============== ==============
15. Right-of-use assets
The Company holds one lease, an office property lease for 21 Gloucester Place, London which expires in September 2022.
Right-of-use assets 31 March 2021 31 March 2020
GBP000s GBP000s
--------------------- -------------- --------------
As at 1 April 2020 221 -
Additions 176 346
Depreciation (140) (125)
As at 31 March 2021 257 221
--------------------- -------------- --------------
Current - 221
Non-current 257 -
--------------------- -------------- --------------
As at 31 March 2021 257 221
===================== ============== ==============
During FY21 the lease of the Company's office in London was extended to September 2022. Additions to right-of-use assets include extensions to existing lease agreements.
Lease liability 31 March 2021 31 March 2020
GBP000s GBP000s
--------------------- -------------- --------------
Current 189 133
Non-current 96 88
--------------------- -------------- --------------
As at 31 March 2021 285 221
===================== ============== ==============
The incremental borrowing rate used in the calculation of the lease liability was 3% (FY20: 3%). The maturity analysis of the finance lease liability is included in note 28.
Amounts recognised in the Statement of Comprehensive Income 31 March 2021 31 March 2020
GBP000s GBP000s
------------------------------------------------------------- -------------- --------------
Total interest expense 48 64
Amounts recognised in the Statement of Cashflows 31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------------------------------- -------------- --------------
Total cash outflow (153) (189)
16.Trade and other receivables
31 March 2021 31 March 2020
GBP000s GBP000s
Amounts falling due in excess of one year:
Trade receivables 10,660 443
Amounts falling due within one year:
Gross trade receivables 9,570 5,195
Less:
Specific provisions (1,919) (314)
Allowance for expected credit loss (560) (107)
------------------------------------------------------- -------------- --------------
Trade receivables 7,091 4,774
------------------------------------------------------- -------------- --------------
Other receivables - 500
Contract asset 431 -
Prepayments 166 180
Total trade and other receivables due within one year 7,688 5,454
======================================================= ============== ==============
Trade receivables are amounts due from settled cases in the ordinary course of business. Trade receivables are recognised initially at the amount of consideration that is unconditional, unless they contain significant financing components, when they are recognised at fair value. The Company holds the trade receivables with the objective of collecting the contractual cash flows and therefore measures them subsequently at amortised cost using the effective interest method. Ageing of the expected credit loss allowances is included in note 28
In 2020 other receivables comprised of a GBP500k loan due payable by June 2021. The loan was repaid in during FY21 totalling GBP581k including interest of 81k. Interest accrued on the loan of GBP38k was presented within accruals in FY20.
Contract assets relate to accrued interest income due on settlement of the large case completion in FY21.
No impairment provision has been recognised in respect of other receivables or contract assets as there is no past history of impairment losses and future losses are not anticipated.
Movements in the allowance for expected credit losses are as follows:
31 March 31 March
2021 2020
GBP000s GBP000s
------------------------------------------- --------- ---------
At 1 April 2020 107 49
Provisions for impairment during the year 453 58
Unused amounts written back - -
At 31 March 2021 560 107
=========================================== ========= =========
The Company applies the simplified approach in providing for expected credit losses under IFRS 9 which allows the use of the lifetime expected credit loss provision for all trade receivables. In measuring the expected credit losses, trade receivables have been stratified by settlement type and days past due. Expected lifetime expected credit loss rates are based on the payment profiles of sales from January 2019 (post IPO).
17. Cash and cash equivalents
31 March 2021 31 March 2020
GBP000s GBP000s
-------------------------- -------------- --------------
Cash at bank and in hand 1,144 8,371
-------------------------- -------------- --------------
All bank balances are denominated in pounds sterling.
18. Trade and other payables
31 March 2021 31 March 2020
GBP000s GBP000s
---------------------------------------------------- -------------- --------------
Amounts falling due in excess of one year:
Accruals - direct costs 6,602 213
Amounts falling due in one year:
Trade payables 713 416
Accruals - direct costs 1,719 2,052
Other creditors 753 682
Contract liability 291 -
Other taxation and social security 89 80
Total trade and other payables due within one year 3,565 3,230
==================================================== ============== ==============
Trade payables are unsecured and are usually paid within 30 days of recognition. The carrying value of trade and other payables approximates their fair value, as the impact of discounting is not significant.
Accruals - direct costs relates primarily to accrued amounts due to Insolvency Practitioners on the Company's completed cases and accrued legal costs of completed cases. Of the GBP6.6m shown as non-current, GBP5.8m relates to the amounts payable to the Insolvency Practitioner due in more than one year in respect of the large case completion in FY21.
The contract liability relates to interest accruing on the significant financing component in respect of amounts payable to the Insolvency Practitioner on the large case completion during FY21.
19. Deferred tax asset
31 March 31 March
2021 2020
GBP000s GBP000s
---------------------------------------------- --------- ---------
At 1 April 2020 157 46
Deferred tax charged in the income statement
for the period (37) 111
Deferred tax included directly in equity 1 -
---------------------------------------------- --------- ---------
At 31 March 2021 121 157
============================================== ========= =========
Deferred tax has been credited to equity reserve because these movements in deferred tax assets relate to releases and creation of share options.
20. Borrowings
31 March 2021 31 March 2020
GBP000s GBP000s
------------------------------ -------------- --------------
Non-current
Bank loans 7,698 7,526
Lease liability 96 88
------------------------------ -------------- --------------
Total non-current borrowings 7,794 7,614
------------------------------ -------------- --------------
Current
Bank loans - -
Lease liability 189 133
------------------------------ -------------- --------------
Total current borrowings 189 133
============================== ============== ==============
Arrangement fees in relation to a GBP10m loan facility originally set up with HSBC in January 2018 that was subsequently extended to a GBP20m facility with a term of four years from date of extension, in November 2018, are capitalised and amortised over the length of the loan facility, four years.
Gross borrowings are GBP8,000k as at 31 March 2021 but are presented net of HSBC set-up amortised costs of GBP302k above (FY20: GBP474k) and in the Statement of Financial Position. The maturity analysis of bank loans is included in note 28.
The Company has complied with the financial covenants of its borrowing facilities which are assessed on a quarterly basis, during the 2021 and 2020 reporting periods.
Reconciliation of liabilities arising from financing activities:
1 April Non-cash 31 March
2020 Cash flows changes 2021
GBP000s GBP000s GBP000s GBP000s
Bank borrowings 7,526 - 172 7,698
Lease liabilities 221 (154) 218 285
--------------------------------- -------- ----------- ---------- ---------
Total liabilities from financing
activities 7,747 (154) 390 7,983
================================= ======== =========== ========== =========
1 April Non-cash 31 March
2019 Cash flows changes 2020
GBP000s GBP000s GBP000s GBP000s
Bank borrowings - 8,000 (474) 7,526
Lease liabilities - (189) 410 221
--------------------------------- -------- ----------- ---------- ---------
Total liabilities from financing
activities - 7,811 (64) 7,747
================================= ======== =========== ========== =========
The directors consider the carrying value of all financial liabilities to be equivalent to their fair value.
A GBP20,000,000 credit facility was provided on 30 November 2018 by HSBC Bank plc. The Company granted a fixed and floating charge over all of its assets in favour of HSBC Bank plc. The facility term is four years. The interest rate is LIBOR plus a maximum margin of 2.75%, depending on the Company's financial performance against agreed covenants.
We have agreed on 22 June 2021, a new RCF for GBP25m over an initial three-year period to 1 July 2024, with an option to extend by a further year. The new RCF also offers the Company an additional approved but uncommitted GBP10m accordion, if ever required. The interest rate is a maximum 2.9% over SONIA. Under terms of the new agreement, Steven Cooklin is required to maintain a minimum shareholding of 5% of the issued share capital of the Company, and is subject a change in control clause such that no investor may hold more than 30 percent of the voting rights of the Company.
Commitments in relation to leases are payable as follows:
31 March 31 March
2021 2020
GBP000s GBP000s
--------------------------------------- --------- ---------
Within one year 194 193
Less than one but not later than five
years 97 97
Over five years - -
--------------------------------------- --------- ---------
Total 291 290
--------------------------------------- --------- ---------
Future finance charges (6) (69)
--------------------------------------- --------- ---------
Total lease liability 285 221
======================================= ========= =========
21. Share capital
31 March 31 March
2021 2020
Allotted and issued No. No.
---------------------------------- ----------- -----------
Ordinary shares of GBP0.004 each 43,571,425 43,571,425
Voting rights
The holders of ordinary shares are entitled to one voting right per share.
Dividends
The holders of ordinary shares are entitled to dividends out of the profits of the Company available for distribution.
22. Reserves
Share premium
Includes all current and prior year premiums received on issue of share capital.
Share based payment reserve
Includes amounts recognised for the fair value of share options granted in accordance with IFRS 2.
Special non-distributable reserve
A special non-distributable reserve was created in FY19 to ensure there was sufficient reserves held within the Company to satisfy creditors at the time of a conversion of share premium to distributable reserves to allow a dividend to be paid in FY19. The balance on this reserve will decline to nil over time as creditors are paid.
Retained earnings
Includes all current and prior periods retained profits and losses .
23.Share-based payments
The Company operates a number of share-based payment schemes as follows:
CSOP share scheme
The Board has adopted the Manolete Partners Company Share Option Plan (CSOP) to enable conditional share awards to be granted, which may be subject to achievement of performance criteria and the awards are exercisable between three and ten years following their grant. There are no cash-settlement alternatives and the awards are therefore accounted for under IFRS 2 as equity settled share-based payments.
Year ended 31 March 2021
Balance Granted Exercised Balance
brought during the during the Lapsed / carried
Grant date Expiry date Exercise price forward year year forfeited forward
----------- ------------ -------------- ------------- ------------- ------------- -------------- --------------
21/11/2018 21/11/2021 1.12 507,352 - - - 507,352
8/07/2019 08/07/2022 4.45 50,557 - - - 50,557
29/11/2019 29/11/2022 4.65 16,127 - - - 16,127
09/12/2019 09/12/2022 4.3 193,781 - - - 193,781
27/07/2029 27/07/2023 4.15 - 28,912 - (7,228) 21,684
15/03/2021 15/03/2024 2.7 - 11,111 - - 11,111
----------- ------------ -------------- ------------- ------------- ------------- -------------- --------------
767,817 40,023 - (7,228) 800,612
------------------------ -------------- ------------- ------------- ------------- -------------- --------------
Exercisable at the end of the year - - - - -
----------------------------------------- ------------- ------------- ------------- -------------- --------------
Weighted average exercise price 2.22 3.75 - 4.15 2.28
----------------------------------------- ------------- ------------- ------------- -------------- --------------
Year ended 31 March 2020
Balance Granted Exercised Balance
brought during the during the Lapsed / carried
Grant date Expiry date Exercise price forward year year forfeited forward
----------- ------------ -------------- ------------- ------------- ------------- -------------- --------------
21/11/2018 21/11/2021 1.12 701,133 - - (193,781) 507,352
08/07/2019 08/07/2022 4.45 - 50,557 - - 50,557
29/11/2019 29/11/2022 4.65 - 16,127 - - 16,127
09/12/2019 09/12/2022 4.3 - 193,781 - - 193,781
701,133 260,465 - (193,781) 767,817
------------------------ -------------- ------------- ------------- ------------- -------------- --------------
Exercisable at the end of the year - - - - -
----------------------------------------- ------------- ------------- ------------- -------------- --------------
Weighted average exercise price 1.12 4.35 - 1.12 2.22
----------------------------------------- ------------- ------------- ------------- -------------- --------------
No options were exercised or modified during the year ended 31 March 2021.
Options outstanding at 31 March 2021 are exercisable at prices ranging between GBP1.12 and GBP4.65 (FY20: GBP1.12 and GBP4.65) and have a weighted average contractual life of the options outstanding at the reporting date is 11.8 months (FY20: 23 months), as analysed in the table below:
Number of Weighted average
share options remaining contractual
life (months)
Exercise price range FY21 FY20 FY21 FY20
GBP1.12 - GBP1.99 507,352 507,352 7.0 19.0
GBP2.00 - GBP3.99 11,111 - 35.0 -
GBP4.00 - GBP4.65 282,149 260,465 19.6 31.0
--------------------- ------- ------- ----------- -----------
800,612 767,817 11.8 23.1
--------------------- ------- ------- ----------- -----------
Number of share Exercise price
options GBP
No.
FY21 FY20 FY21 FY20
CSOP Options 187,559 154,764 2.77 2.58
Unapproved Options 613,053 613,053 2.13 2.13
Total 800,612 767,817 2.28 2.22
=================== ======== ======= ======= =======
Fair Value Calculations
The fair value of the CSOP share option plans are calculated at the date of the grant using the Black-Scholes option pricing model. Expected volatility was determined by calculating the historical volatility of the Company's share price over an appropriate period. The following table presents the inputs used in the option pricing model for the share options granted in the years ended 31 March 2021 and 31 March 2020 based on information at the date of grant:
Grant date Share price at Expected Risk-free Fair value at of award grant date Exercise price volatility Dividend yield interest rate grant date ------------ ---------------- --------------- ---------------- --------------- ---------------- ---------------- 27/07/2020 4.11 4.15 20% 1.5% 1% 0.50 15/03/2021 2.73 2.70 61% 1.5% 0.2% 1.03 ------------ ---------------- --------------- ---------------- --------------- ---------------- ----------------
No performance conditions were included in the fair value calculations for CSOP awards granted during the year.
Long-Term Incentive Plan
In FY21 the Company introduced an equity-settled Long-Term Incentive Plan (LTIP) scheme for the executive directors and other senior executives. Performance is measured at the end of the three-year performance period. If the required minimum Earnings Per Share ("EPS") performance conditions have been satisfied, 25% of the shares will vest increasing to 100% of shares if the maximum EPS target is achieved. Straight-line vesting will apply if performance falls between two points. Options awarded will expire ten years from the date of grant and are issued at the nominal value of the Company's share capital of GBP0.004p but the Company's remuneration committee may waive the requirement at their discretion.
The following table summarises the movements in LTIP options during the year:
Year ended 31 March 2021
Balance Granted Exercised Balance
brought during the during the Lapsed / carried
Grant date Expiry date Exercise price forward year year forfeited forward
----------- ------------ -------------- ------------- ------------- ------------- -------------- --------------
30/09/2020 30/03/2021 0.004 - 53,333(1) - (53,333) -
30/09/2020 30/03/2022 0.004 - 53,333(1) - - 53,333
30/09/2020 30/03/2023 0.004 - 321,334(1) - - 321,334
- 428,000 - (53,333) 374,667
------------------------ -------------- ------------- ------------- ------------- -------------- --------------
Weighted average exercise price - 0.004 - 0.004 0.004
----------------------------------------- ------------- ------------- ------------- -------------- --------------
1. The LTIP amounts above are the maximum potential conditional share awards that may vest subject to the performance conditions.
No options were exercised during the period as the awards did not vest and no options were modified. The weighted average remaining contractual life of these options is 21.3 months (FY20: Nil). No LTIP options were in issue prior to the 1 April 2020.
Fair Value Calculations
The fair value of the LTIP share option plans are calculated at the date of the grant using the Black-Scholes option pricing model. Expected volatility was determined by calculating the historical volatility of the Company's share price over an appropriate period. The following table presents the inputs used in the option pricing model for the share options granted in the years ended 31 March 2021 and 31 March 2020 based on information at the date of grant:
Grant date Share price at Expected Risk-free Fair value at of award grant date Exercise price volatility Dividend yield interest rate grant date ------------ ---------------- ---------------- ---------------- --------------- ---------------- --------------- 30/09/2020 GBP3.05 GBP0.004 20% 1% 0.5% 3.00
30/09/2020 GBP3.05 GBP0.004 20% 1% 0.5% 2.97 30/09/2020 GBP3.05 GBP0.004 20% 1% 0.5% 2.94 ------------ ---------------- ---------------- ---------------- --------------- ---------------- ---------------
LTIP awards granted during the year ended 31 March 2021 are subject to the Earnings Per Share performance conditions.
24.Commitments and contingences
Capital commitments
There were no capital commitments at 31 March 2021 .
Contingent liabilities
There were no contingent liabilities at 31 March 2021.
25. Retirement benefits
The Company operates a defined contribution pension scheme for all qualifying employees. During the year, the Company charged GBP73,953 (FY20: GBP63,317) as employer's pension contributions. The outstanding pension creditor as at 31 March 2021 was GBP4,765 (FY20: GBP6,265).
26. Financial instruments - classification and measurement
Financial assets
Financial assets measured at amortised cost comprise trade receivables, other receivables, contract assets and cash, as follows:
31 March 2021 31 March 2020
GBP000s GBP000s
Trade receivables 17,751 5,217
Other receivables - 500
Contract assets 431 -
Cash and cash equivalents 1,144 8,371
--------------------------- -------------- --------------
Total 19,326 14,088
=========================== ============== ==============
Financial assets measured at fair value through profit or loss comprise of investments:
31 March 2021 31 March 2020
GBP000s GBP000s
Investments 37,508 32,415
------------- -------------- --------------
Total 37,508 32,415
============= ============== ==============
Financial liabilities
Financial liabilities measured at amortised cost comprise of: trade and other payables, bank loans, and lease liabilities, as follows:
31 March 2021 31 March
2020
GBP000s GBP000s
Trade and other payables 10,167 3,443
Bank loans 7,698 7,526
Lease liabilities 285 221
Total 18,150 11,190
========================== ============== =========
Fair Value
The fair value of investments is determined as set out in the accounting policies in Note 2. The fair value hierarchy of financial instruments measured at fair value is provided below:
31 March 2021 Level 1 Level 2 Level 3
GBP000s GBP000s GBP000s
---------------- --------- --------- --------
Investments - - 37,508
---------------- --------- --------- --------
Total - - 37,508
================ ========= ========= ========
31 March 2020 Level 1 Level 2 Level 3
GBP000s GBP000s GBP000s
---------------- --------- --------- --------
Investments - - 32,415
---------------- --------- --------- --------
Total - - 32,415
================ ========= ========= ========
27. Cashflow information
(a) Non-cash adjustments to cashflows generated from operations
31 March 31 March
2021 2020
GBP000s GBP000s
------------------------------------------------------------- --------- ---------
Fair value movements (3,405) (10,900)
Legal costs on realised cases 4,199 1,599
Finance expense 457 445
Depreciation & amortisation 161 -
Share based payments 122 (63)
Finance income (50) (89)
Non-cash change in lease liability (7) -
Non-cash adjustments to cashflows generated from operations 1,477 (9,008)
============================================================== ========= =========
(b) Net debt reconciliation
31 March 31 March
2021 2020
GBP000s GBP000s
--------------------------------------- --------- ---------
Cash and cash equivalents 1,144 8,371
Borrowings - repayable after one year (7,698) (7,526)
---------------------------------------- --------- ---------
Net (debt) / cash excluding leases (6,554) 845
---------------------------------------- --------- ---------
Current lease liability (189) (133)
Non-current lease liability (96) (88)
Net (debt) / cash including leases (6,839) 624
======================================== ========= =========
28. Financial instruments - risk management
The Company's activities expose it to a variety of financial risks: market risk (including cash flow interest rate risk), investment risk, liquidity risk and credit risk. Risk management is carried out by the Board of Directors. The Company uses financial instruments to provide flexibility regarding its working capital requirements and to enable it to manage specific financial risks to which it is exposed.
The Company finances its operations through a mixture of equity finance, bank debt, cash and liquid resources and various items such as trade receivables and trade payables which arise directly from the Company's operations.
Interest rate risk
Interest rate risk is the risk that the fair value of future cash flows associated with the instrument will fluctuate due to changes in market interest rates. Interest bearing assets including cash and cash equivalents are short-term liquid assets. It is the Company's policy to settle trade payables within the credit terms allowed and the Company does therefore not incur interest on overdue balances. No sensitivity analysis has been prepared as the impact on the financial statements would not be significant.
The interest rate profile of the Company's borrowings is shown below:
31 March 31 March
2021 2020
Debt Interest Debt Interest
GBP000s Rate GBP000s Rate
-------------------------- -------- -------------------------- -------- --------------------------
Floating rate borrowings
Bank loans 8,000 LIBOR and Margin of 2.25% 8,000 LIBOR and Margin of 1.75%
========================== ======== ========================== ======== ==========================
Liquidity risk
The Company seeks to maintain sufficient cash balances. Management reviews cash flow forecasts on a regular basis to determine whether the Company has enough cash reserves to meet future working capital requirements and to take advantage of business opportunities.
Unused borrowing facilities at the reporting date:
31 March 2021 31 March 2020
GBP000s GBP000s
Bank loans 12,000 12,000
The following table details the Company's remaining contractual maturity for the Company's non-derivative financial liabilities with agreed maturity periods. The table is presented based on the undiscounted cashflows of the financial liabilities based on the earliest date on which the Company can be required to pay which may differ from the carrying liabilities at the reporting date.
Total Carrying
At 31 March Less than one Between 1 and Between 2 and Greater than 5 contractual amount of
2021 year 2 years 5 years years cashflows liabilities
GBP000s GBP000s GBP000s GBP000s GBP000s GBP000s
Non-interest
bearing
Trade and other
payables 3,298 618 3,411 6,616 13,943 10,167
Interest
bearing
Bank borrowings - 8,000 - - 8,000 7,698
Lease
liabilities 194 97 - - 291 285
Total 3,492 8,715 3,411 6,616 22,234 18,150
================ =============== =============== =============== =============== =============== ===============
Total Carrying
At 31 March Less than one Between 1 and Between 2 and Greater than 5 contractual amount of
2020 year 2 years 5 years years cashflows liabilities
GBP000s GBP000s GBP000s GBP000s GBP000s GBP000s
Non-interest
bearing
Trade and other
payables 3,230 213 - - 3,443 3,443
Interest
bearing
Bank borrowings - - 8,000 - 8,000 7,526
Lease
liabilities 193 97 - - 290 221
Total 3,423 310 8,000 - 11,733 11,190
================ =============== =============== =============== =============== =============== ===============
Capital risk management
The Company is both equity and debt funded, and these two elements combine to make up the capital structure of the business. Equity comprises share capital, share premium and retained earnings and is equal to the amount shown as 'Equity' in the balance sheet. Debt comprises bank loans which are set out in further detail above and in note 20 and leases set out in further detail in note 15. The Company initially raised funds through an IPO in December 2018 and has drawn down GBP8m of a HSBC loan facility in 2020, the total facility is a GBP20m revolving credit facility with HSBC.
The Company's current objectives when maintaining capital are to:
-- Safeguard the Company's ability as a going concern so that it can continue to pursue its growth plans.
-- Provide a reasonable expectation of future returns to shareholders.
-- Maintain adequate financial flexibility to preserve its ability to meet financial obligations, both current and long term.
The Company sets the amount of capital it requires in proportion to risk. The Company manages its capital structure and adjusts it in the light of changes in economic conditions and the risk characteristics of underlying assets. In order to maintain or adjust the capital structure, the Company may issue new shares or sell assets to reduce debt.
During the year ended 31 March 2021 the Company's strategy remained unchanged.
31 March 2021 31 March 2020
GBP000s GBP000s
Net debt / (cash) 6,839 (624)
Total equity 38,928 34,922
-------------------------- -------------- --------------
Net debt to equity ratio 17.6% (1.8%)
========================== ============== ==============
Loan covenants:
Under the terms of existing HSBC RCF facility in place during the year ended 31 March 2021, the Company was required to comply with the following financial covenants:
- Interest Cover in respect of any Relevant Period shall not be less than 5.0:1; - Leverage in respect of any relevant period shall not exceed 2.0:1;
- Asset cover (defined as the ratio of WIP to total net debt) shall not be less than 1.5:1 at any time; and
- In respect of all cases settled in any relevant period, the total realised income shall be greater than 50% of the total maximum unrealised income.
Under the terms of the new GBP25m RCF facility signed on 22 June 2021 there were the following amendments to the financial covenants:
- Leverage in respect of any relevant period shall not exceed 2.75:1 at 30 September 2021, decreasing to 2.25:1 at 31 December 2021, decreasing to 2.0:1 from 31 March 2022; and
- Asset cover (defined as the ratio of trade debtors to total net debt) shall not be less than 1.5:1 at any time.
The Company has complied with the financial covenants of its borrowing facilities which are assessed on a quarterly basis, during the 2021 and 2020 reporting periods.
Credit risk and impairment
Credit risk refers to the risk that a counterparty will default on its contractual obligations resulting in financial loss to the Company. The maximum exposure to credit risk is the carrying value of its financial assets recognised at the reporting date, as summarised below:
31 March 2021 31 March 2020
GBP000s GBP000s
Trade and other receivables 18,348 5,897
Total 18,348 5,897
============================= ============== ==============
The Company applies the simplified approach in providing for expected credit losses under IFRS 9 which allows the use of the lifetime expected credit loss provision for all trade receivables. In measuring the expected credit losses, trade receivables have been stratified by settlement type and days past due. Expected lifetime expected credit loss rates are based on the payment profiles of sales from January 2019 (post IPO).
The Company attempts to assess the probability of credit losses but seeks to mitigate its credit risk by undertaking rigorous net worth checks before taking on a case. Occasionally, credit defaults do sometimes occur when counterparties default on an agreed settlement, payable by instalments.
There is a concentration risk in relation to the trade receivable of GBP9.6m in relation to a single case which completed in the year. Repayments to date have been made according to the agreed schedule. The Company does not consider any concentration of risk within either trade or other receivables to be significant. The Company seeks to obtain charging orders over the property of trade receivables as security. The receivables' ageing analysis is also evaluated on a regular basis for potential doubtful debts. It is the directors' opinion that no further provision for doubtful debts is required.
The following table contains an analysis of our total gross trade receivables segmented by settlement type.
31 March 2021 31 March 2020
GBP000s GBP000s
Settlement agreements 15,739 3,755
Judgements 2,572 1,568
Fully impaired assets 1,919 314
------------------------------------------------- -------------- --------------
Gross carrying amount after specific provisions 20,230 5,637
------------------------------------------------- -------------- --------------
Loss allowance (2,479) (421)
------------------------------------------------- -------------- --------------
Trade receivables carrying amount 17,751 5,216
================================================= ============== ==============
Analysis of trade receivables stratified by settlement type, is as follows:
Past due at 31 March 2021(1) Current 0-1 months 1-3 months 3-6 months 6-12 months > 12 months Total
GBP000s GBP000s GBP000s GBP000s GBP000s GBP000s GBP000s
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Gross receivables
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Settlement agreements 15,378 97 114 51 - 99 15,739
Judgements 3 30 1,198 149 558 634 2,572
Fully impaired assets 101 1 652 27 340 798 1,919
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Total 15,482 128 1,964 227 898 1,531 20,230
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Loss allowance
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Settlement agreements (174) (10) (61) (44) - (11) (300)
Judgements (0) (3) (252) - - (5) (260)
Specific provisions (101) (1) (652) (27) (340) (798) (1,919)
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Total (275) (14) (965) (71) (340) (814) (2,479)
----------------------------- -------- ----------- ----------- ----------- ------------ ------------ -------
Expected loss rate
%
Settlement agreements 1% 10% 54% 86% - 12% 2%
---- ---- ---- ---- ---- ---- ----
Judgements(2) 3% 10% 21% - - 1% 10%
---- ---- ---- ---- ---- ---- ----
Specific provisions 100% 100% 100% 100% 100% 100% 100%
---- ---- ---- ---- ---- ---- ----
Total 2% 11% 49% 31% 38% 53% 12%
---- ---- ---- ---- ---- ---- ----
1. Prior to FY21, the Company applied a general provision of GBP107k based on 2% of gross trade receivables in addition to the specific provision of GBP314k recognised in FY20.
2. Expected judgement loss rates are shown net of deductions where the Company has secured charging orders over properties owned by debtors.
Credit risk on cash and cash equivalents is considered to be very low as the counterparties are all substantial banks with high credit ratings.
Investment risk
Investment risk refers to the risk that the Company's case investments may increase or decrease in value.
Sensitivity analysis has not been included in the financial statements, due to the vast amount of inputs and number of variables which are inherently specific to each case, making it impossible to provide meaningful data. Whilst the Board considers the methodologies and assumptions adopted in the valuation are supportable, reasonable and robust, because of the inherent uncertainty of valuation, it is reasonably possible, on the basis of existing knowledge, that outcomes within the next financial year that are different from the assumptions could require a material adjustment to the carrying amount of the GBP37.5m of investments disclosed in the balance sheet. However, as an indication we note that a 10% increase/(decrease) in the fair value of our top 20 cases (including Cartel cases) would result in an increase/(decrease) in the fair value investment of +/- GBP2.13m."
Currency risk
The Company is not exposed to any currency risk at present.
29 . Related party transactions
Director and key management remuneration is disclosed in Note 5.
Dividends of GBP329,144 were paid to the directors during the year based on their individual shareholdings disclosed in the Remuneration Committee report as follows:
31 March 2021 31 March 2020
GBP000s GBP000s
---------------------------------------- -------------- --------------
Steven Cooklin 327 156
Mark Tavener - -
Peter Bertram 0.5 0.3
Lee Manning 0.6 0.3
Stephen Baister 0.9 0.4
Total dividends paid to the director's 329 157
======================================== ============== ==============
30. Ultimate controlling party
The Company has no ultimate controlling party.
31. Post balance sheet events
We agreed on 22 June 2021 a new GBP25million Banking Facility with HSBC to support the growth of the business. This Revolving Credit Facility is for 3 years and has the option to extend for another year together with a further approved but uncommitted GBP10 million accordion. Details are set out in the CFO report.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
FR DLLFLFQLXBBB
(END) Dow Jones Newswires
June 23, 2021 02:00 ET (06:00 GMT)
1 Year Manolete Partners Chart |
1 Month Manolete Partners Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
